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Abstract Lectins from Aegopodium podagraria (APA), Bryo-
nia dioica (BDA), Galanthus nivalis (GNA), Iris hybrid (IRA) 
and Sambucus nigra (SNA1), and a new lectin-related protein 
from Sambucus nigra (SNLRP) were studied to ascertain 
whether they had the properties of ribosome-inactivating proteins 
(RIP). IRA and SNLRP inhibited protein synthesis by a cell-free 
system and, at much higher concentrations, by cells and had 
polynucleotide:adenosine glycosidase activity, thus behaving like 
non-toxic type 2 (two chain) RIP. APA and SNA1 had much less 
activity, and BDA and GNA did not inhibit protein synthesis. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Plant lectins are a heterogeneous group of proteins with 
highly specific recognition and binding properties. Although 
their biological function has not yet been unambiguously 
demonstrated, their preferential binding to glycoconjugates 
present on the surface of microbes or on epithelial cells along 
the intestinal tract of their potential predators has been inter-
preted as an argument in favour of a defence-related role 
(reviewed in [1]). The high affinity of plant lectins for animal 
glycans is not only important for their presumed defence role 
but is also the basis for their use in studying glycoconjugates 
and as cell-recognition molecules in biological and biomedical 
research. 
Some lectins, in addition to their carbohydrate-binding do-
main^), also possess a domain with a different biological ac-
tivity. Thus, lectins belonging to the group of type 2 'ribo-
some-inactivating proteins' (RIP) consist of a sugar-binding 
B-chain linked to an active A-chain which irreversibly dam-
ages eukaryotic ribosomes through an enzymatic mechanism. 
The A-chains of type 2 RIP have similar enzymatic activity of, 
and are highly homologous to, the so-called type 1 RIP which 
consist of a single polypeptide of about 30 kDa and possibly 
evolved from a common ancestor (reviewed in [2]). 
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The enzymatic activity of type 1 RIP and of the A-chains of 
type 2 RIP was identified as an rRNA N-glycosidase (re-
viewed in [3]) which removes a single adenine from rRNA 
(A4324 from rat liver rRNA; A2f,6o from Escherichia coli 
rRNA). It was subsequently found that some RIP release 
more than one adenine from rRNA [4] and deadenylated 
RNA of other types, poly(A) and DNA [5-8], thus being 
polynucleotide :adenosine glycosidases. 
Type 2 RIP were considered to be very potent toxins, the 
best known being ricin. The B-chains of these proteins bind to 
galactosyl-terminated receptors on the surface of most cells, 
allowing entry of the A-chain inside the cell where it inacti-
vates ribosomes, with consequent arrest of protein synthesis 
and death of the cell. However, some lectins were identified 
which had structure, specificity and enzymatic activity similar 
to ricin and related toxins and still were scarcely toxic to cells. 
This group includes Ricinus communis agglutinin [9], nigrin b 
and SNA1 from Sambucus nigra L. (elderberry) [10-13], ebulin 
1 from Sambucus ebulus L. [14], the lectin from Eranthis hye-
malis (winter aconite) [15] and cinnamomin from Cinnamo-
mum camphor a [16]. 
The presumed defensive role of some lectins may, at least in 
part, depend on their enzymatic activity. For instance, the 
antiviral activity of some type 2 RIP (reviewed in [17]) may 
depend not only on their ribosome-inactivating property but 
also on polynucleotide :adenosine glycosidase activity [5-8]. It 
is evident, however, that the carbohydrate-binding specificity 
of B-chain also strongly influences the toxicity of the type 2 
RIP since it is the determining factor in recognition of the 
target cells. 
The present investigation was undertaken to ascertain (i) 
whether some lectins with specificity for similar sugars (from 
Aegopodium podagraria, Bryonia dioica, Iris hybrid and Sam-
bucus nigra) and a new lectin-related protein (from Sambucus 
nigra), all of which resemble type 2 RIP with respect to their 
heterodimeric structure, have RIP activity and, if so, (ii) 
whether they also exhibit polynucleotide :adenosine glycosi-
dase activity. The study was extended to a mannose-specific 
lectin, Galanthus nivalis agglutinin, with homotetrameric 
structure. We observed that a lectin from Iris hybrid and a 
lectin-related protein from the bark of Sambucus nigra indeed 
have RIP and polynucleotide :adenosine glycosidase activities, 
with low cytotoxicity. 
2. Materials and methods 
2.1. Proteins 
The following proteins were purified as described in the respective 
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references: /V-acetylgalactosamine-specific lectins from Aegopodium 
podagraria (APA) [18], Bryonia dioica (BDA) [19], and Iris hybrid 
(IRA) [20], the Neu5Ac(a2,6)Gal/GalNac-specific Sambucus nigra ag-
glutinin I (SNA1) [13,21]; a Sambucus nigra lectin-related protein 
(SNLRP) [22]; the mannose-specific Galanthus nivalis agglutinin 
(GNA) [23]. Like type 2 RIP, IRA and BDA contain a single pair 
of unequal subunits. Whilst no sequence data are available for BDA, 
N-terminal sequencing of IRA demonstrated that its A-chain defi-
nitely has strong sequence similarity with the A-chain of ricin and 
abrin [20]: in particular, the residues G21, F24 and R29 common to 
all RIP (numbers refer to ricin sequence) are present and aligned. It is 
not known, however, whether the active site residues characteristic of 
RIP have been conserved in IRA. SNA1 has been identified as a type 2 
RIP composed of four [A-s-s-B]-pairs [13]. SNLRP is built up of a 
single [A-s-s-B]-pair and inhibits cell-free protein synthesis but is 
devoid of carbohydrate-binding activity [22]. Molecular cloning dem-
onstrated that both SNAI and SNLRP contain the active site residues 
characteristic of RIP [13,22]. APA, a 480 kDa octamer composed of 
two types of non-covalently-bound subunits with similar Μτ, appar-
ently differs from type 2 RIP but has amino acid composition similar 
to SNAI [21] and BDA [18]. No sequence data are available for APA. 
Finally, GNA which is a homotetramer of four 12 kDa subunits and 
has no sequence similarity with any RIP [23], was examined as an 
example of a lectin completely different from type 2 RIP. 
2.2. Cell lines 
The cell lines used, namely mouse 3T3 (fibroblasts), and human 
HeLa (carcinoma) and BeWo (chorioncarcinoma) were maintained 
as monolayer cultures in RPMI-1640 medium supplemented with anti-
biotics and 10% foetal calf serum (20% for BeWo cells), in a humidi-
fied atmosphere containing 5% CO2 at 37°C. Subcultures were ob-
tained by trypsin treatment of confluent cultures. The JM cell line 
(monocyte-derived) was grown in suspension in the same medium 
and treated with phorbolmyristate acetate to induce adhesion as de-
scribed [24]. 
2.3. Protein synthesis 
Protein synthesis was determined with a cell-free system (a rabbit 
reticulocyte lysate) as described previously [24]. Reaction mixtures 
contained, in a final volume of 62.5 μΐ: 10 mM Tris-HCl buffer (pH 
7.4), 100 mM ammonium acetate, 2 mM magnesium acetate, 1 mM 
ATP, 0.2 mM GTP, 15 mM phosphocreatine, 3 μg of creatine kinase, 
0.05 mM amino acids (minus leucine), 89 nCi of L-[14C]leucine (240 
Ci/mol), and 25 μΐ of rabbit reticulocyte lysate. Incubation was at 
28°C for 5 min. When indicated, lectins and SNLRP were reduced 
by incubation at 37°C for 30 min with 20 mM 2-mercaptoethanol 
immediately prior to assay. 
Protein synthesis by various cell lines was assayed as described 
previously [25]. Cells (105/well) were incubated with seven scalar doses 
of lectin or SNLRP (between 2 x l 0 ~ 1 3 and 2X10~6 M) for 18 h, 
followed by a 2 h pulse with L-[4,5-3H]leucine (125 nCi/0.25 ml, spe-
cific activity 85 Ci/mmol). 
IC50 (concentration causing 50% inhibition) was calculated by lin-
ear regression analysis. 
2.4. N-glycosidase activity 
TV-glycosidase activity was assayed by measuring adenine released 
from different substrates (ribosomes, DNA, poly(A), rRNA). Ribo-
somes prepared from a rabbit reticulocyte lysate as described in [26] 
were a generous gift from Dr. M. Brigotti. Poly(A) and rRNA from 
E. coli (16S+23S) were from Boehringer GmbH (Mannheim, Ger-
many). DNA from herring sperm (hsDNA from Sigma Chemical 
Co., St. Louis, MO) was treated for 2.5 h at 37°C with DNase-free 
RNase A (Boehringer), then it was repeatedly precipitated in ethanol 
to remove the enzyme [6]. 
Reaction mixtures contained, in a final volume of 50 μΐ, 50 mM 
sodium acetate buffer (pH 4.0), 100 mM KC1, 19 pmol ribosomes or 
20 μg of polynucleotide substrates, and 5 μg of protein to be tested. 
After a 40 min incubation at 30°C, the reaction was arrested and 
adenine released was determined by HPLC as described previously 
[6]. When indicated, the proteins were reduced as for protein synthesis 
determination. 
2.5. Binding to, uptake and degradation by cells 
IRA was labelled with 125I by the Iodogen reagent as described [27]. 
The day before the experiments cells were trypsinised and seeded in 
24-well trays. Binding to, and uptake and degradation by HeLa cells 
were determined as described previously [28] with minor modifica-
tions. Briefly, the cells (0.5 X106) were incubated at 37°C for the 
indicated time in 0.5 ml of Hepes-buffered complete medium with 
1 0-8 M i25 j . l a b e l l e d lectin (i .30±0.19x 10
5 cpm/5 pmol). The uptake 
was arrested by moving the culture to ice. The medium was removed, 
adjusted to 10% trichloroacetic acid (w/v, final concentration) and 
centrifuged to determine the acid-soluble radioactivity as a measure 
of the degradation and exocytosis of degraded lectin. The cells were 
washed once with cold complete medium and three times with phos-
phate-buffered saline (pH 7.5) and were stripped for 30 min at 0°C 
with 0.1 M glycine-HCl buffer (pH 2), containing 0.04 M NaCl, to 
quantitate the membrane-bound IRA. The cells were then washed 
once with phosphate-buffered saline (pH 7.5), and were extracted at 
37°C for 10 min with 0.1 M KOH to measure the intracellular accu-
mulation of lectin. Parallel cultures were incubated at 0°C and the 
values obtained were subtracted from those obtained at 37°C, as a 
correction for background radioactivity. The internalisation of IRA 
was calculated as the sum of the intracellular and degraded protein. 
The concentration of nucleic acid was measured from the .4260 
corrected for protein concentration by the formula: 62.9x^260-
36x^280· The values obtained were compared by ANOVA test [29]. 
3. Results 
3.1. Protein synthesis 
Among tested proteins, IRA and SNLRP inhibited cell-free 
protein synthesis with IC50S below 20 nM, i.e. within the 
range observed with other RIP (Table 1). In the case of 
IRA the inhibition was 10 times stronger when the lectin 
was reduced prior to assay. APA and SNAI had a 20-130 
Table 1 
Effect of lectins and SNLRP on protein synthesis 
APA BDA 
Cell-free protein synthesis IC50
a (nM) 
Reduction 
192 > 1500 
+ 111 >1500 
Protein synthesis by cell linesb IC5o
a (nM) 
BeWo > 200 n.d.c 
HeLa > 200 n.d.c 
JM > 200 n.d.c 
3T3 > 200 n.d.c 
GNA 
> 1500 
> 1500 
n.d.c 
n.d.c 
n.d.c 
n.d.c 
IRA 
18.3 
1.67 
12.7± 1.00 
134 ±2.67 
89.3 ± 
10.0 ± 
18.7 
8.33 
SNAI 
370 
225 
72.9 ±14.2 
>400 
>400 
>400 
SNLRP 
6.03 
5.74 
409 ±79.4 
> 1500 
863 ±393 
84.0 ±9.56 
aICeo: concentration of lectins or SNLRP inhibiting protein synthesis by 50% as compared to controls calculated by linear regression analysis 
(Ä±SD = 0.99 ±0.01 and 0.95 ±0.05 for cell-free and for cellular protein synthesis, respectively). 
bResults are mean values ± SD of two experiments performed in triplicate. Incorporation of [3H]leucine by cells in the absence of lectins or SNLRP 
(controls) was (dpm±SD): BeWo 16343±2548, HeLa 21102± 199, JM 9895±2239, and 3T3 3606± 1071. 
cn.d.: not determined. 
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Fig. 1. Dose-response curves of adenine released by Iris hybrid ag-
glutinin from various polynucleotidic substrates. The indicated 
amounts of unreduced Iris hybrid agglutinin were incubated at 30°C 
for 40 min with 20 μg of either (■) hsDNA, ( A ) poly(A), or (·) 
rRNA. Controls were run with complete assay components but ag-
glutinin (<6 pmol adenine were spontaneously released from all 
substrates). Adenine released (pmol/min/pmol of enzyme) was calcu-
lated from linear regression analysis and was: 3.11 from hsDNA, 
0.16 from poly(A) and 0.08 from rRNA. 
times lower inhibitory activity, BDA and GNA were not in-
hibitory at the highest concentration tested. 
The proteins with inhibitory activity on cell-free protein 
synthesis were tested for inhibition of protein synthesis by 
cells. Consistently with the effects on cell-free protein synthe-
sis, IRA was the most active lectin, especially on 3T3 and 
BeWo cells, followed by SNLRP to which, again, 3T3 fibro-
blasts were the most sensitive. SNA1 inhibited protein synthe-
sis by Be Wo cells only, and APA had no effect up to 200 nM 
(Table 1). It should be noted that the inhibitory effect was 
different on various cell lines, HeLa cells being the most re-
sistant. In all cases the inhibition was much less than that 
exerted by ricin, which inhibits cellular protein synthesis 
with IC50 several orders of magnitude lower [2]. 
3.2. N-glycosidase activity 
All proteins active on protein synthesis had iV-glycosidase 
357 
activity, releasing less than one residue of adenine per ribo-
some, whereas GNA, which does not affect protein synthesis, 
had no effect on ribosomes. When tested on substrates other 
than ribosomes, only IRA and SNLRP had a marked N-gly-
cosidase activity, which was greater on hsDNA than on 
rRNA and poly(A) (Table 2). As for cell protein synthesis, 
SNA1 showed some activity, whereas APA and BDA had only 
traces of activity. It should be noted that the activity on DNA 
was generally decreased after reduction of the proteins. Dose-
response curves of Iris hybrid agglutinin on various polynu-
cleotidic substrates (Fig. 1) showed a linear ratio between 
enzyme concentration and adenine released. 
3.3. Binding to, uptake and degradation by cells 
The endocytosis of IRA, the protein with the highest RIP 
and N-glycosidase activities, was studied with HeLa cells (Fig. 
2). A significant two-factor interaction was found between 
binding, intracellular accumulation, degradation and total in-
ternalisation, versus the variable time by ANOVA (F-3.49; 
dfXSni; P = 0.0002). The protein bound was almost undetect-
able, and the amount internalised by the cells was very small 
(3.7 pmol/mg nucleic acid after 6 h incubation) as compared 
with ricin (45.5 pmol/mg nucleic acid) and also lower than the 
corresponding amount of the non-toxic type 2 RIP nigrin b 
(53.2 pmol/mg nucleic acid) [30]. Interestingly, the intracellu-
lar accumulation of IRA (2.4 pmol/mg nucleic acid) was sim-
ilar to that of nigrin b (1.9 pmol/mg nucleic acid), and both 
values were lower than that of ricin (9.6 pmol/mg nucleic acid 
[30]. 
4. Discussion 
The inhibition of protein synthesis by the active proteins 
can be attributed to their ,/V-glycosidase activity. The proteins 
even at high concentration removed no more than a single 
adenine molecule per ribosome, as most RIP do, presumably 
at the ricin/sarcin site. Moreover, like all RIP tested so far [8], 
they acted also on hsDNA, which appeared to be the best 
among non-ribosomal substrate. The polynucleotide:adeno-
sine glycosidase activity of the proteins reflected the effect 
on cell-free protein synthesis, IRA and SNLRP being the 
most active and the only ones with some activity also on 
poly(A) and rRNA as substrates. The activity of SNA1 and 
APA was scarce and limited to DNA, whilst BDA was inac-
tive. The reduced proteins were less active on DNA, as it was 
observed with ricin [8], whereas their effect on protein syn-
Table 2 
7V-glycosidase activity 
Reduction 
Adenine released (pmol) from: 
Ribosomes hsDNA 
(+) 
poly(A) rRNA 
(-) 
37 
4 
6894 
213 
2147 
(+) 
25 
4 
4505 
129 
1144 
(-) 
0 
1 
212 
3 
25 
(+) 
0 
0 
271 
0 
11 
(-) 
1 
4 
99 
3 
47 
(+) 
1 
3 
125 
2 
42 
APA 
BDA 
IRA 
SNA1 
SNLRP 
8.44 
n.d. 
8.63 
9.27 
9.04 
Lectins or SNLRP (5 μg) were incubated at 30°C for 40 min with 19 pmol of rabbit reticulocyte ribosomes or 20 μg of polynucleotides under the 
experimental conditions described in the text. 
Values obtained in the absence of lectins or SNLRP (controls) were subtracted, and were 4.9 (ribosomes), 6.9 (hsDNA), 6.0 (poly(A)) and 0 (rRNA) 
pmol of adenine. 
Results are mean of duplicate determinations, n.d.: not determined. 
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Fig. 2. Internalisation of Iris hybrid agglutinin by HeLa cells. Cells 
were incubated for the indicated time, with 10~8 M 125I-labelled lec-
tin. Binding to (·), and intracellular accumulation ( A ) and degra-
dation by (D), HeLa cells of IRA were measured as described [28]. 
The internalisation (■) was calculated as the sum of the intracellular 
and degraded protein. Results are given (means ± SE) of four experi-
ments in triplicate samples. 
thesis was enhanced after reduction. The different steric hin-
drance of ribosomes and hsDNA may account for this differ-
ence, since the disulfide bond is not involved in the active site 
configuration, as judged from crystallographic studies on RIP 
(reviewed in [2]). 
Consistently with these results, IRA and SNLRP affected 
protein synthesis by cells, again with IC50S much lower than 
ricin and related toxins [2]. The chorioncarcinoma-derived 
BeWo cell line was very sensitive to these proteins, con-
sistently with previous results [31]. This high sensitivity of 
BeWo cells probably explains why these cells were the only 
ones inhibited by SNA1, in spite of the low activity of this 
lectin on the cell-free system. The marked inhibition of 3T3 
cell line protein synthesis was unexpected, since fibroblastic 
cells were generally rather resistant to other RIP [2]. As a 
whole, these results confirm the different sensitivity to RIP 
observed with various cell lines [2] and seem to indicate that 
the action of type 2 RIP on cells depends on the character-
istics both of the cells and of the RIP. 
5. Conclusion 
(i) IRA can be considered as a non-toxic type 2 RIP like 
nigrin b [30] and cinnamomin [16], on the basis of its structure 
and of the effect on cell-free and cell protein synthesis, and of 
its polynucleotide:adenosine glycosidase activity. The inhibi-
tion of protein synthesis by cells caused by this lectin, and 
consequently its cytotoxicity, are lower as compared with ri-
cin. This may be accounted for by the extremely low binding 
of IRA to the cells, inferior to that of nigrin b which in turn is 
lower than that of ricin and similar toxic type 2 RIP. More-
over, only 65% of the bound lectin accumulated inside the 
cytoplasm after internalization, the remaining following a 
pathway leading to degradation and extrusion from the cells. 
(ii) SNLRP also strongly resembles type 2 RIP as far as the 
enzymatic activity is concerned, but differs in that the B-chain 
lacks a sugar binding site, and this accounts for the low cy-
totoxicity. Its inhibitory activity on cell-free protein is not 
affected by reduction, possibly because the B-chain does not 
hinder the active site of the A-chain. 
(iii) The action of SNA1 and APA is not clear, since these 
lectins have a low enzymatic activity, possible due to their 
polymeric structure. Furthermore, SNA1 inhibits protein syn-
thesis by BeWo cells only. 
(iv) It is confirmed that BDA [19] has no RIP activity and, 
consistently, no polynucleotide:adenosine glycosidase activity. 
As expected, GNA, which is totally unrelated to RIP, has no 
enzymatic activity. 
Acknowledgements: This study was supported in Bologna by the Uni-
versity of Bologna, Funds for selected research topics, the MURST, 
the CNR, special projects 'Biotecnologie e Biostrumentazione' and 
'ACRO', the Associazione Nazionale per la Ricerca sul Cancro, and 
the Pallotti's Legacy for Cancer Research and in Leuven by grants 
from the National Fund for Scientific Research (Belgium, Grant 
G.0223.97). W.J.P. is Research Director and E.J.M.V.D. is Postdoc-
toral Fellow of this fund. 
References 
[1] W.J. Peumans, E.J.M. Van Damme, Histochem. J. 27 (1995) 
253-271. 
[2] L. Barbieri, M.G. Battelli, F. Stirpe, Biochim. Biophys. Acta 
1154(1993)237-282. 
[3] Y. Endo, K. Tsurugi, J. Biol. Chem. 263 (1988) 8735-8739. 
[4] L. Barbieri, J.M. Ferreras, A. Barraco, P. Ricci, F. Stirpe, Bio-
chem. J. 286 (1992) 1-4. 
[5] L. Barbieri, P. Gorini, P. Valbonesi, P. Castiglioni, F. Stirpe, 
Nature 372 (1994) 624. 
[6] L. Barbieri, P. Valbonesi, P. Gorini, A. Pession, F. Stirpe, Bio-
chem. J. 319 (1996) 507-513. 
[7] F. Stirpe, L. Barbieri, P. Gorini, P. Valbonesi, A. Bolognesi, L. 
Polito, FEBS Lett. 382 (1996) 309-312. 
[8] L. Barbieri, P. Valbonesi, E. Bonora, P. Gorini, A. Bolognesi, F. 
Stirpe, Nucl. Acid Res. 25 (1997) 518-522. 
[9] S. Olsnes, Methods Enzymol. 50 (1978) 330-335. 
[10] T. Girbés, L. Chores, J.M. Ferreras, M.A. Rojo, R. Iglesias, R. 
Muñoz, F.J. Arias, M. Calonge, J.R. Garcia, E. Méndez, Plant 
Mol. Biol. 22 (1993) 1181-1186. 
[11] L. Chores, R. Iglesias, R. Muñoz, J.M. Ferreras, P. Jimenez, T. 
Girbés, J. Exp. Bot. 45 (1994) 513-516. 
[12] T. Girbés, L. Chores, F.M. de Benito, R. Iglesias, J.M. Ferreras, 
Biochem. J. 315 (1996) 343-344. 
[13] E.J.M. Van Damme, A. Barre, P. Rouge, F. Van Leuven, W.J. 
Peumans, Eur. J. Biochem. 235 (1996) 128-137. 
[14] T. Girbés, L. Citores, R. Iglesias, J.M. Ferreras, R. Muñoz, M.A. 
Rojo, F.J. Arias, J.R. Garcia, E. Méndez, M. Calonge, J. Biol. 
Chem. 268 (1993) 18195-18199. 
[15] M.A. Kumar, D.E. Timm, K.E. Neel, W.G. Owen, W.J. Peu-
mans, A.G. Rao, J. Biol. Chem. 268 (1993) 25176-25183. 
[16] J. Ling, W.-Y. Liu, Cell Biochem. Funct. 14 (1996) 157-161. 
[17] M.G. Battelli, F. Stirpe, in: M. Chessm, D. DeBorde, A. Zipf 
(Eds.), Antiviral proteins in higher plants, CRC Press, Boca Ra-
ton, FL, 1995, pp. 39-64. 
[18] W.J. Peumans, M. Nsimba-Lubaki, B. Peeters, W.F. Broekaert, 
Planta 164 (1985) 75-82. 
[19] W.J. Peumans, M. Nsimba-Lubaki, A.R. Carlier, E. Van Dries-
sche, Planta 160 (1984) 222-228. 
[20] H. Mo, E.J.M. Van Damme, W.J. Peumans, I.J. Goldstein, 
J. Biol. Chem. 269 (1994) 7666-7673. 
[21] W.F. Broekaert, M. Nsimba-Lubaki, B. Peeters, W.J. Peumans, 
Biochem. J. 221 (1984) 163-169. 
[22] E.J.M. Van Damme, A. Barre, P. Rouge, F. Van Leuven, W.J. 
Peumans, J. Biol. Chem. 272 (1997) 8353-8360. 
[23] E.J.M. Van Damme, H. Kaku, F. Perini, I.J. Goldstein, B. Pee-
M.G. Battelli et al.lFEBS Letters 408 (1997) 355-359 359 
ters, F. Yagi, B. Decock, W.J. Peumans, Eur. J. Biochem. 202 
(1991) 23-30. 
[24] A. Bolognesi, F. Olivieri, M.G. Battelli, L. Barbieri, A.I. Falasca, 
A. Párente, F. Del Vecchio Blanco, F. Stirpe, Eur. J. Biochem. 
228 (1995) 935-940. 
[25] J.M. Ferreras, L. Barbieri, T. Girbés, M.G. Battelli, M.A. Rojo, 
F.J. Arias, M.A. Rocher, F. Soriano, E. Méndez, F. Stirpe, Bio-
chim. Biophys. Acta 1216 (1993) 31^12. 
[26] S. Sperti, M. Brigotti, M. Zamboni, D. Camicelli, L. Montanaro, 
Biochem. J. 277 (1991) 281-284. 
[27] P.J. Fraker, J.C. Speck Jr., Biochem. Biophys. Res. Commun. 80 
(1978) 849-857. 
[28] M.G. Battelli, L. Polito, A. Bolognesi, L. Lafleur, Y. Fradet, F. 
Stirpe, Int. J. Cancer 65 (1996) 485^190. 
[29] S.A. Glantz, Primer of Biostatistics, McGraw-Hill, New York, 
1987. 
[30] M.G. Battelli, L. Citores, L. Buonamici, J.M. Ferreras, F.M. de 
Benito, F. Stirpe, T. Girbés, Arch. ToxicoL, in press. 
[31] M.G. Battelli, V. Montacuti, F. Stirpe, Exp. Cell Res. 201 (1992) 
109-112. 
